Related Experiment Videos
The bilobectomies for lung cancer.
P Carbognani1, G Tincani, P Solli
1Department of General Thoracic and Vascular Surgery, University of Parma, Parma, Italy. carbogna@ipruniv.cce.unipr.it
The Journal of Cardiovascular Surgery
|June 9, 2001
Summary
Bilobectomy lung cancer surgery is a feasible operation with oncological value, comparable to standard resections. This retrospective study found similar survival rates and complication profiles to other major lung surgeries.
Area of Science:
- Thoracic Surgery
- Surgical Oncology
- Pulmonary Medicine
Background:
- Lung cancer treatment often involves surgical resection.
- Lobectomy and pneumonectomy are standard major lung resections.
- The role of bilobectomy in lung cancer requires further investigation.
Purpose of the Study:
- To evaluate the feasibility and oncological value of bilobectomy for lung cancer.
- To compare outcomes of bilobectomy with other major lung resections.
Main Methods:
- Retrospective analysis of 46 patients undergoing bilobectomy (upper-middle or middle-lower lobectomy) between 1981-1998.
- Comparison of operative mortality, postoperative complications, drainage tube persistence, and hospital stay with right lobectomies.
- Survival analysis using Kaplan-Meier method and log-rank test, compared to right lobectomies and pneumonectomies.
Main Results:
- Overall morbidity was 43.4% and mortality was 6.5%.
- Mean chest tube persistence was 7.8 days and mean hospital stay was 14 days.
- No significant differences in outcomes were found when comparing bilobectomies to right lobectomies; however, pneumoperitoneum in middle-lower lobectomies significantly reduced hospital stay.
Conclusions:
- Bilobectomy is a feasible surgical option for lung cancer.
- The oncological outcomes of bilobectomy are comparable to standard major lung resections.
- Bilobectomy can be considered an equivalent alternative to other standard major lung resections in selected cases.